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Abstract
On the surface electrocardiogram (ECG), an abnormally wide QRS|T angle reflects changes in
regional action potential duration profiles and in direction of repolarization sequence which is
thought to increase the risk of ventricular arrhythmia. We investigated the relationship between
abnormal QRS|T angle and mortality in a nationally representative sample of individuals without
clinically evident heart disease. We studied 7,052 participants ≥ 40 years of age in the Third
National Health and Nutrition Examination Survey (NHANES III) with 12-lead ECGs. Individuals
with self-report or ECG evidence of a prior myocardial infarction, QRS duration ≥120 msec, or
history of heart failure were excluded. Borderline and abnormal spatial QRS|T angle were defined
according to sex-specific 75th and 95th percentiles of frequency distributions. All-cause (n=1093
women, n=1191 men) and cardiovascular mortality (n=462 women, n=455 men) over 14 years
was assessed through linkage with the National Death Index. In multivariable analyses, abnormal
spatial QRS|T angle was associated with an increased hazard ratio (HR) for cardiovascular
mortality in women (HR 1.82, 95% CI 1.05-3.14) and men (HR 2.21, 95% CI 1.32-3.68). An
abnormal QRS|T angle was also associated with increased multivariable adjusted HRs for all-
cause mortality in women (HR 1.30, 95% CI 0.95-1.78) and men (HR 1.87, 95% CI 1.29-2.7).
Borderline QRS|T angle was not associated with increased risk for all-cause or cardiovascular
mortality. In conclusion, abnormal QRS|T angle, as measured on a 12-lead ECG, was associated
with increased risk for cardiovascular and all-cause mortality in this population-based sample
without known heart disease.
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Measures on the 12-lead electrocardiogram (ECG), such as the QT interval, left ventricular
hypertrophy, and ST segment depression, are known to provide prognostic information for
cardiovascular morbidity and mortality.1-4 Spatial QRS|T angle quantifies the deviation in
the direction of ventricular depolarization and repolarization. Abnormally wide QRS|T angle
reflects changes in regional action potential duration profiles and in spatial direction of
repolarization sequence, which may be associated with increased dispersion of
repolarization and malignant arrhythmia.5 Abnormal spatial QRS|T angle has been
associated with all-cause mortality, cardiac mortality, and sudden cardiac death in several
cohorts.3,6-9 One prior study has evaluated the relationship between QRS|T angle and
mortality in individuals without heart disease,6 and it remains unconfirmed if QRS|T angle
is a useful clinical predictor of cardiac outcomes in the general population. We hypothesized
that spatial QRS|T angle, determined from a 12-lead ECG, is an independent predictor of
cardiovascular and all-cause mortality in the general population without known cardiac
disease, and we sought to examine this question in the Third National Health and Nutrition
Examination Survey (NHANES III). A second aim of this study was to determine clinical
correlates associated with abnormal spatial QRS|T angle.
Methods
NHANES III was a stratified, multistage probability survey designed to select a
representative sample of the civilian non-institutionalized United States population. Overall,
10,294 adults 40 years of age and older completed the NHANES III interview and
examination between 1988 and 1994. We excluded 1,809 participants who did not have a
12-lead ECG, 775 participants with a self-report or ECG evidence of a prior myocardial
infarction, 192 with a history of congestive heart failure, 452 participants with a QRS
interval ≥120 msec, and 14 participants without valid ECG data for calculating spatial QRS|
T angle. After these exclusions, a total of 7,052 NHANES III participants were included in
the current analyses. Compared with those who were included in this analysis, the 1809
participants who were excluded due to missing ECGs were noted to be older (63.0±0.7 years
versus 55.9 0.4 years, p<0.001) and more likely to be non-Hispanic black race (15.0%
versus 8.9%, p<0.001). The protocol for NHANES III was approved by the National Center
for Health Statistics of the Center for Disease Control and Prevention Institutional Review
Board. All participants gave written informed consent.
NHANES III baseline data were collected during an in-home interview and a subsequent
visit to a mobile examination center. Data collected during the in-home interview included
demographics, physical activity, smoking, use of antihypertensive and cholesterol lowering
medication, and a history of stroke.
Using height and weight measured during the visit to the mobile examination center, body
mass index was calculated as weight in kilograms divided by height in meters squared.
Blood pressure was measured three times during the in-home interview and three additional
times during the visit to the mobile examination center. All blood pressure measurements for
each participant were averaged. Serum C-reactive protein was quantified using latex-
enhanced nephelometry, a low sensitivity assay, and levels ≥3 mg/L were defined as
elevated. Plasma glucose was measured using an enzymatic reaction. Diabetes mellitus was
defined as a fasting plasma glucose ≥126 mg/dL, a non-fasting plasma glucose ≥200 mg/dL
and/or a self-reported history of diabetes with concurrent use of anti-diabetes medication.
Total serum cholesterol and HDL-cholesterol were measured enzymatically. Serum
creatinine was measured by the Jaffe modified kinetic method. Estimated glomerular
filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology
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Collaboration (CKD-EPI) equation after aligning the serum creatinine concentrations with
the assay employed in the development of the equation.10,11 Reduced eGFR was defined as
<60 ml/min/1.73m2. A spot urine sample was collected and albuminuria defined as a urinary
albumin to creatinine concentration ≥30 mg/g.
ECGs were recorded on a Marquette MAC 12 system (Marquette Medical Systems, Inc.
Milwaukee, WI) by trained technicians during the participant’s visit to the mobile
examination center. Computerized analysis of the ECG data was performed using
Minnesota12 and Novacode13 algorithms. Coding included rhythm analysis, detection of
ECG abnormalities, and selective averaging to obtain representative durations and
amplitudes of ECG components.
The spatial QRS|T angle was approximated by a simple algorithm derived from ECG data
file of the Atherosclerosis Research in Communities (ARIC) study,14 which uses a
combination of 3 QRS and 3 T wave peak-to-peak amplitudes available in the NHANES III
public release ECG data file. The reported correlation between QRS|T angle from the simple
algorithm and that from matrix transformation of the 12-lead ECGs was 0.87, and the
sensitivity of this simple method for detecting abnormal QRS|T angle was 0.88 and the
specificity was 0.91.
We classified spatial QRS|T angle two ways. First, we categorized QRS|T angle values
according to the sex-specific frequency distribution as abnormal (≥95th percentile),
borderline (≥75th and <95th percentile), and normal (<75th percentile) as previously
described.6 The 75th and 95th percentiles were 90° and 121° for women, respectively, and
107° and 136° for men, respective ly. Second, based on a prior study in an elderly sample
we categorized spatial QRS|T angle as abnormal (135 to 180°), borderline (105 to 135°) and
normal (0 to 105°). 7
In addition, we calculated frontal plane QRS|T angle as the absolute difference between the
frontal plane QRS axis and T axis.6 We defined normal, borderline, and abnormal frontal
plane QRS|T angle according to the sex-specific 75th (39° and 81° for women and men,
respectively) and 95th (43° and 95° for women and men, respectively) percentiles of its
distribution.
NHANES III participants have been followed for mortality through December 31, 2006. The
method of probabilistic matching was used to link NHANES III participants with the
National Death Index to identify vital status and, for those who died, cause of death.
Matching was based on 12 identifiers for each participant including Social Security number,
sex, and date of birth. Follow-up for each study participant was calculated as the time
between their NHANES III examination and the date of death or December 31, 2006,
whichever occurred first. Cause of death was determined using the underlying cause listed
on death certificates. The ICD-9 was used for deaths occurring between 1988 and 1998 and
ICD-10 for deaths during 1999 and 2006. Cardiovascular (CVD) mortality was defined by
any of ICD-9 codes 390-434 and 436-459; ICD-10 codes I00-I99.
As the distribution of the QRS|T angle may differ for men and women, a priori, we chose to
conduct all analyses stratified by sex. Baseline characteristics of the study population, mean
or percentage, were calculated for each level of spatial QRS|T angle (normal, borderline, or
abnormal). Using logistic regression models, factors associated with abnormal spatial QRS|T
angle were calculated. Factors investigated included age, race/ethnicity, heart rate, being
physically inactive, current smoking, body mass index, systolic blood pressure,
antihypertensive medication use, total and high-density lipoprotein cholesterol, cholesterol
lowering medication use, elevated C-reactive protein, diabetes, reduced eGFR, albuminuria,
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and history of stroke, simultaneously. Initial models included age and race/ethnicity with
subsequent models including all variables simultaneously.
Cox proportional hazards regression was used to calculate the age-race/ethnicity and
multivariable adjusted hazard ratios and 95% confidence intervals (CI) for all-cause and
CVD-related mortality associated with borderline and abnormal, compared to normal,
spatial QRS|T angle. The multivariable adjusted hazard ratio for all-cause and CVD-related
mortality were also calculated for spatial QRS|T angle modeled as a continuous variable
using restricted quadratic splines with knots at the 75th, and 95th percentiles of the spatial
QRS|T distribution. Two sensitivity analyses were conducted. First, the age-race/ethnicity
and multivariable adjusted hazard ratios for all-cause and cardiovascular mortality were
calculated using cut-points of <135°, 105 to 135°, and ≥135° to define normal, borderline,
and abnormal spa tial QRS|T angles, respectively. Second, hazard ratios were calculated for
borderline and abnormal, versus normal frontal plane QRS|T angle.
Data were analyzed using SUDAAN (version 9.0; Research Triangle Institute, Research
Triangle Park, NC) to account for the complex NHANES sampling design, including data
clustering and unequal probabilities of selection, over-sampling, and non-response.
NHANES III sampling weights were applied in all analyses.
Results
Baseline characteristics of women and men included in this analysis, according to normal,
borderline and abnormal spatial QRS|T angle, are presented in Table 1. Men and women
with an abnormal QRS|T angle were older and more likely to be non-Hispanic black. In age-
and race-adjusted, gender specific analyses, body mass index, systolic blood pressure,
antihypertensive medication use, diabetes mellitus, and albuminuria were associated with
abnormal QRS|T angle. After multivariable adjustment, smoking, systolic blood pressure
and albuminuria were associated with abnormal QRS|T angle in women (Table 2), while in
men only cholesterol-lowering medication use and diabetes mellitus were associated with
abnormal QRS|T angle.
Over a median follow-up of 14 years, mortality both in women and men was highest among
those with abnormal QRS|T angle, followed by those with borderline QRS|T angle (Table
3). After adjustment for age and race/ethnicity, among both men and women, abnormal
QRS|T angle was associated with an increased hazard ratio for all-cause and cardiovascular
mortality. After multivariable adjustment, abnormal QRS|T angle was associated with a non-
significant elevated risk of all-cause mortality in women and with significantly increased
risk in men. Abnormal QRS|T angle was significantly associated with increased risk of
cardiovascular mortality both in women and in men. The associations with all-cause and
cardiovascular mortality were similar when using pre-specified levels for defining
borderline and abnormal QRS|T angle (Table 4). In both women and men, abnormal QRS|T
angle according to pre-specified levels was significantly associated both with all-cause
mortality and cardiovascular mortality in multivariable analyses. When analyzed as a
continuous variable, the risk of all-cause and cardiovascular mortality increased
substantially for QRS|T angle values approximately >90°, whereas for men the mortality r
isk increased at QRS|T angle values approximately >120° (Figure 1).
Among men, abnormal frontal plane QRS|T angle was associated with increased risk for all-
cause and cardiovascular mortality in both age-race/ethnicity and multivariable adjusted
models (Supplemental Table 1). In women, abnormal frontal plane QRS|T angle was not
associated either with all-cause mortality or cardiovascular mortality after multivariable
adjustment.
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In the current analysis, an abnormal spatial QRS|T angle was a strong, independent predictor
of long-term all-cause and cardiovascular mortality. Our results are similar to the finding by
Zhang et al. in the Atherosclerosis Risk in Communities study of increased mortality risk in
individuals without known heart disease.6 Our study extends prior analyses by utilizing a
nationally representative sample of US adults without known heart disease to estimate the
relationships between spatial QRS|T angle and cardiovascular mortality. In addition, we
examined potential nonlinearity of the relationships. Of note, the spline analyses indicated
that the mortality risk rises monotonically once threshold values for abnormal QRS|T angle
are reached, and that these thresholds are different for men (>120°) and women (>90°).
In NHANES III, an abnormal QRS|T angle was associated with several known
cardiovascular risk factors, most strongly with smoking, systolic blood pressure and
albuminuria in women and with diabetes mellitus in men. Prior smaller studies have also
documented relationships between abnormal QRS|T angle and blood pressure,1516
diabetes,17 and smoking.18 Compared with these studies, the current analysis used a larger
sample size and adjusted for a greater number of potential confounders, allowing us to find
that there were different clinical correlates of abnormal QRS|T angle depending on gender.
In this analysis we excluded participants with previous myocardial infarction, heart failure,
and/or prolonged QRS duration, so that individuals with overt cardiac disease were less
likely to be included. Our results suggest that an abnormal QRS|T angle as derived from a
12-lead ECG may be a marker for subclinical cardiac disease, as well as a mortality
indicator. Based on our findings, abnormal QRS|T angle in individuals without known heart
disease may warrant further clinical evaluation in order to manage cardiac risk factors,
inform prognosis, and pursue potential treatments to reduce the cardiac mortality risk.
Our results also suggest a potential clinical utility, in men, of the frontal plane QRS|T angle,
derived as the difference between QRS axis and T axis available in the reports of most ECG
programs and which was also predictive for mortality in multivariable analyses. The analysis
by Zhang et al. found in both men and women that frontal planar QRS|T angle was suitable
for risk stratification.6 However, other analyses have suggested that spatial QRS|T angle
outperforms frontal plane QRS|T angle as a risk predictor for ventricular arrhythmia in
defibrillator patients19 and as an indicator for heart disease.20 Further evaluation of the
settings in which frontal plane QRS|T angle is suitable for risk prediction is warranted,
especially given the ease with which it can be calculated from a 12-lead ECG.
Among the limitations in our study, we used an approximation for spatial QRS|T angle from
the 12-lead ECG that does not incorporate a matrix transformation. While this approach
used may not be as precise as matrix-based approaches,21 prior data suggests a high
correlation between the two approaches.14 In addition, we lacked echocardiographic
measures of left ventricular function to complement the other clinical predictors in our
analyses. Therefore, we cannot compare the prognostic utility of QRS|T angle to this
measure of risk estimation. Also, data were unavailable for specific non-fatal cardiovascular
outcomes such as ventricular arrhythmia, which has been associated with abnormal QRS|T
angle in high-risk cohorts.19,22
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Multivariable adjusted hazard ratios for all-cause (top panels) and cardiovascular mortality
(bottom panels) associated with spatial QRS|T angle, modeled as a continuous variable
using restricted quadratic splines. Spline knots were placed at the 75th and 95th percentiles
of the spatial QRS/T angle distribution for women (90° and 121°, respectively) and men
(107° and 136°, respect ively).
Multivariable adjustment includes age, race/ethnicity, sex, body mass index, physical
inactivity, current smoking, systolic blood pressure, antihypertensive medication use, heart
rate, diabetes, total and HDL-cholesterol, cholesterol lowering medication use, C-reactive
protein ≥ 3 mg/L, reduced estimated glomerular filtration rate, albuminuria, and a history of
stroke.
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Table 1











Age, years 56.1 (0.4) 57.1 (0.9) 60.5 (1.1)
Race/ethnicity
 Non-Hispanic white 86.5% 88.4% 83.3%
 Non-Hispanic black 9.7% 8.9% 14.0%
 Mexican-American 3.8% 2.7% 2.7%
Physically inactive 28.9% 32.5% 36.0%
Current smoking 19.2% 20.3% 27.9%
Body mass index (kg/m2) 27.1 (0.2) 27.3 (0.4) 28.5 (0.7)
Systolic blood pressure (mmHg) 125.6 (0.5) 130.5 (1.1) 136.3 (1.7)
Antihypertensive medication use 19.0% 23.4% 38.8%
Heart rate (beats per minute) 68.6 (0.3) 70.9 (0.6) 70.7 (1.7)
Total cholesterol (mg/dL) 219.1 (1.1) 227.0 (2.2) 228.4 (3.6)
High-density lipoprotein cholesterol
 (mg/dL)
56.2 (0.6) 55.9 (0.9) 53.4 (1.4)
Cholesterol-lowering medication use 4.6% 4.6% 8.0%
C-reactive protein ≥ 3 mg/L 38.2% 40.1% 49.3%
Diabetes mellitus 5.9% 11.8% 18.6%
Estimated glomerular filtration rate < 60
 ml/min/1.73 m2
8.4% 10.5% 13.5%
Albuminuria ≥ 30 mg/g 7.5% 13.6% 23.5%











Age, years 54.7 (0.4) 55.4 (0.8) 58.8 (1.4)
Race/ethnicity
 Non-Hispanic white 87.4% 84.7% 80.7%
 Non-Hispanic black 8.4% 11.5% 15.4%
 Mexican-American 4.3% 3.9% 3.9%
Physically inactive 16.1% 17.5% 22.5%
Current smoking 24.6% 29.9% 31.1%
Body mass index (kg/m2) 27.3 (0.2) 27.0 (0.2) 28.2 (0.5)
Systolic blood pressure (mmHg) 127.7 (0.6) 131.9 (1.1) 136.7 (2.3)
Antihypertensive medication use 14.6% 14.9% 27.3%
Heart rate (beats per minute) 66.4 (0.4) 67.3 (0.6) 69.8 (1.4)
Total cholesterol (mg/dL) 212.5 (1.4) 214.1 (2.1) 211.7 (5.9)
High-density lipoprotein cholesterol
 (mg/dL)
45.3 (0.5) 45.8 (0.9) 46.0 (2.1)
























Cholesterol-lowering medication use 3.8% 3.1% 9.3%
C-reactive protein ≥ 3 mg/L 27.2% 31.0% 44.1%
Diabetes mellitus 8.1% 12.1% 21.5%
Estimated glomerular filtration rate < 60
 ml/min/1.73 m2
5.0% 5.8% 7.6%
Albuminuria ≥ 30 mg/g 7.6% 13.5% 23.6%
Prior history of stroke 2.1% 2.3% 2.9%
Numbers in table are mean (standard error) or percentage
The cut-points for normal, borderline, and abnormal represent the 75th (90 to 120 and 107 to 135 for women and men, respectively) and 95th
percentiles (≥121 and ≥136 for women and men, respectively) of the spatial QRS|T angle distribution of NHANES III after applying population
weights.
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Table 2
Odds ratios for having an abnormal spatial QRS|T angle.
Variable Age-race adjusted
odds ratio (95% CI)
WOMEN MEN
Age, 10 years 1.30 (1.15 – 1.48) 1.32 (1.11 – 1.57)
Race/ethnicity
 Non-Hispanic white 1 (ref) 1 (ref)
 Non-Hispanic black 1.73 (1.21 – 2.49) 2.08 (1.31 – 3.31)
 Mexican-American 0.95 (0.64 – 1.42) 1.21 (0.64 – 2.32)
Physically inactive 1.18 (0.72 – 1.93) 1.30 (0.80 – 2.12)
Current smoking 1.82 (1.16 – 2.85) 1.46 (0.89 – 2.40)
Body mass index, 5 kg/m2 1.31 (1.03 – 1.65) 1.19 (1.02 – 1.38)
Systolic blood pressure, 20 mmHg 1.47 (1.20 – 1.80) 1.51 (1.10 – 2.07)
Antihypertensive medication use 2.12 (1.48 – 3.03) 1.82 (1.18 – 2.81)
Heart rate, 10 beats per minute 1.13 (0.90 – 1.41 1.23 (1.02 – 1.49)
Total cholesterol, 40 mg/dL 1.09 (0.94 – 1.26) 0.98 (0.73 – 1.31)
High-density lipoprotein cholesterol, 10
 mg/dL
0.88 (0.78 – 1.00) 1.00 (0.79 – 1.25)
Cholesterol-lowering medication use 1.63 (0.77 – 3.48) 2.53 (1.12 – 5.71)
C-reactive protein ≥ 3 mg/L 1.48 (0.98 – 2.24) 1.77 (1.00 – 3.11)
Diabetes mellitus 2.65 (1.71 – 4.12) 2.46 (1.52 – 3.97)
Estimated glomerular filtration rate < 60
 ml/min/1.73 m2
1.15 (0.66 – 2.02) 1.03 (0.53 – 2.02)
Albuminuria ≥ 30 mg/g 2.69 (1.83 – 3.96) 2.67 (1.54 – 4.64)
History of stroke 2.46 (0.97 – 6.25) 0.94 (0.39 – 2.27)
Multivariable adjusted
odds ratio (95% CI)
WOMEN MEN
Age, 10 years 1.12 (0.93 – 1.34) 1.16 (0.90 – 1.50)
Race/ethnicity
 Non-Hispanic white 1 (ref) 1 (ref)
 Non-Hispanic black 1.30 (0.83 – 2.01) 1.34 (0.74 – 2.42)
 Mexican-American 0.74 (0.48 – 1.15) 0.98 (0.50 – 1.90)
Physically inactive 0.93 (0.59 – 1.44) 1.27 (0.80 – 2.02)
Current smoking 1.98 (1.16 – 3.38) 1.55 (0.87 – 2.78)
Body mass index, 5 kg/m2 1.06 (0.90 – 1.25) 1.16 (0.90 – 1.49)
Systolic blood pressure, 20 mmHg 1.28 (1.03 – 1.59) 1.28 (0.90 – 1.83)
Antihypertensive medication use 1.43 (0.92 – 2.24) 1.30 (0.83 – 2.04)
Heart rate, 10 beats per minute 0.99 (0.78 – 1.27) 1.15 (0.90 – 1.47)
Total cholesterol, 40 mg/dL 0.98 (0.87 – 1.10) 0.91 (0.67 – 1.25)
High-density lipoprotein cholesterol, 10
 mg/dL
0.95 (0.85 – 1.07) 1.10 (0.89 – 1.34)
Cholesterol-lowering medication use 1.46 (0.67 – 3.19) 2.44 (1.00 – 5.99)
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Multivariable adjusted
odds ratio (95% CI)
WOMEN MEN
C-reactive protein ≥ 3 mg/L 1.04 (0.65 – 1.68) 1.42 (0.74 – 2.73)
Diabetes mellitus 1.80 (0.93 – 3.48) 1.83 (1.02 – 3.31)
Estimated glomerular filtration rate < 60
 ml/min/1.73 m2
0.97 (0.53 – 1.80) 0.76 (0.36 – 1.60)
Albuminuria ≥ 30 mg/g 1.96 (1.27 – 3.04) 1.68 (0.91 – 3.10)
History of stroke 1.82 (0.61 – 5.40) 0.78 (0.32 – 1.88)
Abnormal QRS|T angle defined as ≥121° for women and ≥136° for men. Multivariable adjustment includes all of the variables listed in the table in
a single model. Due to missing data 240 men (7.4%) and 314 women (9.0%) were excluded from multivariable analyses.
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Table 3









 Number of deaths (%) 743 (20.6%) 245 (25.9%) 105 (39.1%)
Hazard ratio (95% CI)
 Demographic adjusted 1 (ref) 1.19 (0.99 – 1.44) 1.65 (1.20 – 2.26)
 Multivariable adjusted 1 (ref) 1.16 (0.94 – 1.43) 1.30 (0.95 – 1.78)
Cardiovascular mortality
 Number of deaths (%) 304 (7.9%) 106 (9.3%) 52 (20.2%)
Hazard ratio (95% CI)
 Demographic adjusted 1 (ref) 1.12 (0.80 – 1.56) 2.10 (1.19 – 3.69)









 Number of deaths (%) 814 (23.1%) 265 (26.1%) 112 (51.8%)
Hazard ratio (95% CI)
 Demographic adjusted 1 (ref) 1.07 (0.84 – 1.35) 2.24 (1.57 – 3.19)
 Multivariable adjusted 1 (ref) 0.97 (0.74 – 1.27) 1.87 (1.29 – 2.72)
Cardiovascular mortality
 Number of deaths (%) 291 (7.9%) 102 (9.5%) 62 (24.1%)
Hazard ratio (95% CI)
 Demographic adjusted 1 (ref) 1.13 (0.77 – 1.65) 3.01 (2.10 – 4.31)
 Multivariable adjusted 1 (ref) 1.04 (0.69 – 1.58) 2.21 (1.32 – 3.68)
The cut-points for normal, borderline, and abnormal represent the 75th (90° to 120° and 107° to 135° for women and men, respective ly) and 95th
percentiles (≥121° and ≥136° for women and men, respectively) of the spatia l QRS|T angle distribution of NHANES III after applying population
weights. Multivariable adjustment includes age, race/ethnicity, sex, body mass index, physical inactivity, current smoking, systolic blood pressure,
antihypertensive medication use, heart rate, diabetes, total and high-density lipoprotein cholesterol, cholesterol lowering medication use, C-reactive
protein ≥ 3 mg/L, reduced estimated glomerular filtration rate, albuminuria, and a history of stroke. Due to missing data 240 men (7.4%) and 314
women (9.0%) were excluded from multivariable analyses.
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Table 4










 Number of deaths (%) 883 (21.4%) 149 (26.4%) 61 (56.1%)
Hazard ratio (95% CI)
 Demographic adjusted 1 (ref) 1.13 (0.88 – 1.44) 2.06 (1.53 – 2.76)
 Multivariable adjusted 1 (ref) 1.07 (0.84 – 1.38) 1.46 (1.06 – 2.02)
Cardiovascular mortality
 Number of deaths (%) 364 (8.0%) 69 (11.6%) 29 (28.1%)
Hazard ratio (95% CI)
 Demographic adjusted 1 (ref) 1.28 (0.80 – 2.05) 2.57 (1.61 – 4.10)









 Number of deaths (%)
Hazard ratio (95% CI) 785 (23.1%) 289 (25.7%) 117 (50.7%)
 Demographic adjusted 1 (ref) 1.12 (0.89 – 1.40) 2.17 (1.57 – 3.00)
 Multivariable adjusted 1 (ref) 0.98 (0.75 – 1.28) 1.78 (1.31 – 2.43)
Cardiovascular mortality
 Number of deaths (%)
Hazard ratio (95% CI) 281 (8.0%) 110 (8.9%) 64 (23.7%)
 Demographic adjusted 1 (ref) 1.11 (0.76 – 1.61) 2.89 (2.04 – 4.10)
 Multivariable adjusted 1 (ref) 0.97 (0.63 – 1.48) 2.08 (1.26 – 3.46)
Multivariable adjustment includes age, race/ethnicity, sex, body mass index, physical inactivity, current smoking, systolic blood pressure,
antihypertensive medication use, heart rate, diabetes, total and high-density lipoprotein cholesterol, cholesterol lowering medication use, C-reactive
protein ≥ 3 mg/L, reduced estimated glomerular filtration rate, albuminuria, and a history of stroke. Due to missing data 240 men (7.4%) and 314
women (9.0%) were excluded from multivariable analyses.
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